FIBROSIS

Collagen-targeted MRI contrast agent for liver fibrosis detection

A novel MRI gadolinium-based contrast agent designed to bind with collagen, a key component in liver fibrosis progression, provides direct quantification of collagen deposition in several preclinical liver disease models. This tool could have large implications in clinical diagnosis and drug trials.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Staging fibrosis with magnetic resonance imaging.

References

  1. 1.

    Estes, C. et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J. Hepatol. 69, 896–904 (2018).

  2. 2.

    Salarian, M. et al. Early detection and staging of chronic liver diseases with a protein MRI contrast agent. Nat Commun 10, 4777 (2019).

  3. 3.

    Tapper, E. B. & Lok, A. S. F. Use of liver imaging and biopsy in clinical practice. N. Engl. J. Med. 377, 756–768 (2017).

  4. 4.

    Zarski, J. P. et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J. Hepatol. 56, 55–62 (2012).

  5. 5.

    Kennedy, P. et al. Quantitative elastography methods in liver disease: current evidence and future directions. Radiology 286, 738–763 (2018).

  6. 6.

    Hernandez-Gea, V. & Friedman, S. L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 6, 425–456 (2011).

  7. 7.

    Farrar, C. T. et al. CM-101: Type I collagen-targeted MR imaging probe for detection of liver fibrosis. Radiology 287, 581–589 (2018).

  8. 8.

    Xue, S. H. et al. Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging. Proc. Natl Acad. Sci. USA 112, 6607–6612 (2015).

  9. 9.

    Ellis, E. L. & Mann, D. A. Clinical evidence for the regression of liver fibrosis. J. Hepatol. 56, 1171–1180 (2012).

  10. 10.

    Sumida, Y. & Yoneda, M. Current and future pharmacological therapies for NAFLD/NASH. J. Gastroenterol. 53, 362–376 (2018).

Download references

Author information

Correspondence to Bachir Taouli.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kennedy, P., Taouli, B. Collagen-targeted MRI contrast agent for liver fibrosis detection. Nat Rev Gastroenterol Hepatol 17, 201–202 (2020). https://doi.org/10.1038/s41575-020-0266-z

Download citation